Locations:
Search IconSearch

Tag: chemotherapy

Dr. Mustafa Ali & patient
September 4, 2025/Cancer/Blood Cancers

Comparison of First-Line Chemotherapy for Adults with Acute Lymphoblastic Leukemia

Questions remain about the merits of asparaginase-based therapy

Julie Lang, MD
January 2, 2025/Cancer/News & Insight

Real-World Insights of KEYNOTE-522 Regimen Adoption for Treating Triple-Negative Breast Cancer

Real-world results reporting aims to make treatments safer and more effective

rendering of Doxorubicin molecules
December 13, 2024/Cancer/News & Insight

Research Offers Further Insight into Chemo Scheduling for Early Breast Cancer

Phase 3 trial found no survival differences between weekly or biweekly doxorubicin/cyclophosphamide or between weekly or biweekly paclitaxel

DNA
October 10, 2024/Cancer/Research

Blocking YES1 Protein Resensitizes Triple-Negative Breast Cancer to Treatment

Obstructing key protein allows for increased treatment uptake for taxane chemotherapy

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Women's health physician
April 16, 2024/Cancer

Watching Out for Primary Ovarian Insufficiency

An underdiagnosed condition in patients with cancer

23-CNR-4318382-CQD-Hero-650×450 Dr Hill
December 19, 2023/Cancer/Research

Active Surveillance may be a Feasible Option for a Subset of Patients with Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Large cohort study finds no reduction in survival for patients managed with active surveillance compared to treated patients

DNA
April 27, 2023/Cancer/Genomics

Gene Expression Signature Predicts Patients’ Response to Cisplatin

Research enables precision medicine beyond patients with changed mutational status

Photomicrograph of Acute Myeloblastic Leukemia (AML), a cancer of white blood cell
December 28, 2021/Cancer/Blood Cancers

Uproleselan May Improve Remission, Reduce Side Effects in Patients with Acute Myeloid Leukemia

Study finds drug safe and effective when combined with chemotherapy

Chimeric antigen receptor (CAR) therapy,
December 14, 2021/Cancer/Blood Cancers

Biomarkers Predict Outcomes of CAR T-Cell Therapy in Patients with Diffuse Large B-Cell Lymphoma

Treatment may be a lifesaving option for patients with relapsed or refractory disease

BackPage 1 of 2Next

Advertisement

Ad